Nedd4 haploinsufficient mice display moderate insulin resistance, enhanced lipolysis, and protection against high-fat diet-induced obesity

Endocrinology (United States)

Volumn 156, Issue 4, 2015, Pages 1283-1291

  Li, Jing Jing ^a   Jr, Robert J Ferry ^a,b   Diao, Shiyong ^a   Xue, Bingzhong ^c   Bahouth, Suleiman W ^a   Liao, Francesca Fang ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b University of Memphis   (United States)

^c GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; GLUCOSE; INSULIN; UBIQUITIN PROTEIN LIGASE NEDD4; ESCRT PROTEIN; GLUCOSE BLOOD LEVEL; NEDD4 UBIQUITIN PROTEIN LIGASES; UBIQUITIN PROTEIN LIGASE;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET INDUCED OBESITY; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HAPLOINSUFFICIENCY; HISTOLOGY; IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; LIPID DIET; LIPID STORAGE; LIPOLYSIS; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; WEIGHT GAIN; ANIMAL; BODY WEIGHT; GENETICS; METABOLISM; OBESITY; SEXUAL DEVELOPMENT; SIGNAL TRANSDUCTION;

ADIPOCYTES; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIET, HIGH-FAT; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; FEMALE; HAPLOINSUFFICIENCY; INSULIN; INSULIN RESISTANCE; LIPOLYSIS; MALE; MICE; MICE, KNOCKOUT; OBESITY; SEX CHARACTERISTICS; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 84926472070     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1909     Document Type: Article

References (46)

1. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635-643.
2. Choquet H, Meyre D. Molecular basis of obesity: current status and future prospects. Curr Genomics. 2011;12:154-168.
3. Sun Y. Targeting E3 ubiquitin ligases for cancer therapy. Cancer Biol Ther. 2003;2:623-629.
4. Ardley HC, Robinson PA. The role of ubiquitin-protein ligases in neurodegenerative disease. Neurodegener Dis. 2004;1:71-87.
5. Song R, Peng W, Zhang Y, et al. Central role of E3 ubiquitin ligase MG53 in insulin resistance and metabolic disorders. Nature. 2013;494:375-379.
6. Marino A, Menghini R, Fabrizi M, et al. ITCH deficiency protects from diet-induced obesity. Diabetes. 2014;63:550-561.
7. Hirasaka K, Kohno S, Goto J, et al. Deficiency of Cbl-b gene enhances infiltration and activation of macrophages in adipose tissue and causes peripheral insulin resistance in mice. Diabetes. 2007;56:2511-2522.
8. Abe T, Hirasaka K, Kagawa S, et al. Cbl-b is a critical regulator of macrophage activation associated with obesity-induced insulin resistance in mice. Diabetes. 2013;62:1957-1969.
9. Molero JC, Jensen TE, Withers PC, et al. c-Cbl-deficient mice have reduced adiposity, higher energy expenditure, and improved peripheral insulin action. J Clin Invest. 2004;114:1326-1333.
10. Molero JC, Waring SG, Cooper A, et al. Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance. Diabetes. 2006;55:708-715.
11. Hoppe T, Matuschewski K, Rape M, Schlenker S, Ulrich HD, Jentsch S. Activation of a membrane-bound transcription factor by regulated ubiquitin/proteasome-dependent processing. Cell. 2000;102:577-586.
12. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006;7:678-689.
13. Magnifico A, Ettenberg S, Yang C, et al. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J Biol Chem. 2003;278:43169-43177.
14. Vecchione A, Marchese A, Henry P, Rotin D, Morrione A. The Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptor. Mol Cell Biol. 2003;23:3363-3372.
15. Kwak YD, Wang B, Li JJ, et al. Upregulation of the E3 ligase Nedd4-1 by oxidative stress degrades IGF-1 receptor protein in neurodegeneration. J Neurosci. 2012;32:10971-10981.
16. Persaud A, Alberts P, Hayes M, et al. Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function. EMBO J. 2011;30:3259-3273.
17. Liu Y, Oppenheim RW, Sugiura Y, Lin W. Abnormal development of the neuromuscular junction in Nedd4-deficient mice. Dev Biol. 2009;330:153-166.
18. Li JJ, Dolios G, Wang R, Liao FF. Soluble β-amyloid peptides, but not insoluble fibrils, have specific effect on neuronal microRNA expression. PLoS One. 2014;9:e90770.
19. Fischer AH, Jacobson KA, Rose J, Zeller R. Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc. 2008;2008:pdb prot4986.
20. Qiao L, Kinney B, Schaack J, Shao J. Adiponectin inhibits lipolysis in mouse adipocytes. Diabetes. 2011;60:1519-1527.
21. Viswanadha S, Londos C. Optimized conditions for measuring lipolysis in murine primary adipocytes. J Lipid Res. 2006;47:1859-1864.
22. Viswanadha S, Londos C. Determination of lipolysis in isolated primary adipocytes. Methods Mol Biol. 2008;456:299-306.
23. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes. 1996;45:1455-1462.
24. Cao XR, Lill NL, Boase N, et al. Nedd4 controls animal growth by regulating IGF-1 signaling. Sci Signal. 2008;1:ra5.
25. Wang X, Trotman LC, Koppie T, et al. Nedd4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell. 2007;128:129-139.
26. Kwak YD, Wang B, Pan W, Xu H, Jiang X, Liao FF. Functional interaction of phosphatase and tensin homologue (PTEN) with the E3 ligase Nedd4-1 during neuronal response to zinc. J Biol Chem. 2010;285:9847-9857.
27. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest. 2011;121:2094-2101.
28. de Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem. 2008;54:945-955.
29. Fan CD, Lum MA, Xu C, Black JD, Wang X. Ubiquitin-dependent regulation of phospho-AKT dynamics by the ubiquitin E3 ligase, Nedd4-1, in the insulin-like growth factor-1 response. J Biol Chem. 2013;288:1674-1684.
30. Zhang J, Fu M, Cui T, et al. Selective disruption of PPARγ2 impairs the development of adipose tissue and insulin sensitivity. Proc Natl Acad Sci USA. 2004;101:10703-10708.
31. Kubota N, Terauchi Y, Miki H, et al. PPAR γ mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell. 1999;4:597-609.
32. Pettersson US, Walden TB, Carlsson PO, Jansson L, Phillipson M. Female mice are protected against high-fat diet induced metabolic syndrome and increase the regulatory T cell population in adipose tissue. PLoS One. 2012;7:e46057.
33. Louet JF, LeMay C, Mauvais-Jarvis F. Antidiabetic actions of estrogen: insight from human and genetic mouse models. Curr Atheroscler Rep. 2004;6:180-185.
34. Sharma G, Prossnitz ER. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic β-cells. Endocrinology. 2011;152:3030-3039.
35. Nabhan JF, Pan H, Lu Q. Arrestin domain-containing protein 3 recruits the Nedd4 E3 ligase to mediate ubiquitination of the β2-adrenergic receptor. EMBO Rep. 2010;11:605-611.
36. Shenoy SK, Xiao K, Venkataramanan V, Snyder PM, Freedman NJ, Weissman AM. Nedd4 mediates agonist-dependent ubiquitination, lysosomal targeting, and degradation of the β2-adrenergic receptor. J Biol Chem. 2008;283:22166-22176.
37. Han SO, Kommaddi RP, Shenoy SK. Distinct roles for β-arrestin2 and arrestin-domain-containing proteins in β2 adrenergic receptor trafficking. EMBO Rep. 2013;14:164-171.
38. Patwari P, Emilsson V, Schadt EE, et al. The arrestin domain-containing 3 protein regulates body mass and energy expenditure. Cell Metab. 2011;14:671-683.
39. Ahmadian M, Duncan RE, Varady KA, et al. Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity. Diabetes. 2009;58:855-866.
40. Jaworski K, Ahmadian M, Duncan RE, et al. AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency. Nat Med. 2009;15:159-168.
41. Saha PK, Kojima H, Martinez-Botas J, Sunehag AL, Chan L. Metabolic adaptations in the absence of perilipin: increased β-oxidation and decreased hepatic glucose production associated with peripheral insulin resistance but normal glucose tolerance in perilipin-null mice. J Biol Chem. 2004;279:35150-35158.
42. Tansey JT, Sztalryd C, Gruia-Gray J, et al. Perilipin ablation results in a lean mouse with aberrant adipocyte lipolysis, enhanced leptin production, and resistance to diet-induced obesity. Proc Natl Acad Sci USA. 2001;98:6494-6499.
43. Lowell BB, Bachman ES. β-Adrenergic receptors, diet-induced thermogenesis, and obesity. J Biol Chem. 2003;278:29385-29388.
44. Thien CB, Langdon WY. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Biochem J. 2005;391:153-166.
45. Guo H, Qiao G, Ying H, et al. E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity. Cell Rep. 2012;1:472-482.
46. Abe T, Hirasaka K, Kohno S, et al. Ubiquitin ligase Cbl-b and obesity-induced insulin resistance. Endocr J. 2014;61:529-538.